CONSUMER LAW GROUP has filed a Canadian class action lawsuit against the makers of the diabetes drugs Avandia, Avandamet, and Avandaryl (rosiglitazone), manufactured by GlaxoSmithKline, on behalf of individuals who have suffered from an adverse cardiovascular event.
Adverse cardiovascular events caused by the diabetes drugs Avandia, Avandamet, and Avandaryl (rosiglitazone), includes the following symptoms:
• Heart Attack
• Stroke
• Congestive Heart failure
• Death
• Myocardial Ischemia
• Chest pains
For more information, please visit our CLG website at http://www.clg.org/
JOIN THIS CLASS ACTION TODAY
All residents in Canada who have taken and/or purchased the drug rosiglitazone (sold under the brand name Avandia, Avandamet, and Avandaryl) since March 21st 2000 and their successors, assigns, family members, and dependants are encouraged to sign up for this class action in order to receive compensation.
Only those persons that join the class action and provide their contact information will be eligible for benefits.
Only those persons that join the class action and provide their contact information will be eligible for benefits.
Do not miss out. Please go to http://www.clg.org/Class-Action/List-of-Class-Actions/Avandia-Drug-Side-Effects-National-Class-Action
Subscribe to:
Posts (Atom)